Gattaz, Wagner F <br/><br/>
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study.  [electronic resource] 

 -  Current medical research and opinion  Apr 2014 
 - 695-709 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2013.869201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Delayed-Action Preparations<br/>Female<br/>Humans<br/>Isoxazoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Paliperidone Palmitate<br/>Patient Satisfaction<br/>Prospective Studies<br/>Pyrimidines--administration & dosage<br/>Quality of Life<br/>Risperidone--adverse effects<br/>Schizophrenia--drug therapy<br/>Severity of Illness Index